Jul 26, 2024
Endocrinologist Robert Gabbay, MD, PhD, the ADA’s chief
scientific and medical officer, speaks with JAMA Medical News about
clinical research highlights from the annual meeting, including
some of the latest data on blockbuster weight loss medications,
“game-changing” diabetes technologies, and a new use for a familiar
drug.
Related Content: